Insider Transactions in Q3 2024 at Immunome Inc. (IMNM)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2024
|
Max Rosett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,380
-23.25%
|
$230,080
$16.01 P/Share
|
|
Sep 19
2024
|
Max Rosett Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,000
+40.44%
|
$42,000
$1.05 P/Share
|
|
Aug 19
2024
|
Jack Higgins Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
2,471
-15.44%
|
-
|
|
Aug 16
2024
|
Jean Jacques Bienaime |
BUY
Open market or private purchase
|
Direct |
7,000
+29.64%
|
$91,000
$13.94 P/Share
|
|
Aug 15
2024
|
Jack Higgins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,524
-18.05%
|
$45,812
$13.93 P/Share
|
|
Aug 15
2024
|
Jack Higgins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,524
+50.0%
|
$19,524
$1.35 P/Share
|